<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00449267</url>
  </required_header>
  <id_info>
    <org_study_id>1PN1010614</org_study_id>
    <nct_id>NCT00449267</nct_id>
  </id_info>
  <brief_title>Aurolab Hydrophobic Foldable Intraocular Lens Study</brief_title>
  <official_title>Clinical Evaluation of Hydrophobic Foldable Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurolab</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurolab</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether hydrophobic intraocular lenses manufactured
      by aurolab are safe and effective in the surgical treatment of cataract.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hydrophobic as the name suggests is fear for water. Hydrophobic foldable IOLs are made from
      acrylic material. Aurolab has developed its own hydrophobic acrylic material. This material
      has been subjected to several biocompatibility studies and it has proved itself to be
      biocompatible.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Refraction</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal status</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iritis</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IOL decentration</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IOL tilt</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IOL discoloration</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IOL opacity</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cystoid macular oedema</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypopyon</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endophthalmitis</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pupillary block</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal detachment</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Status of anterior and posterior capsule</measure>
    <time_frame>10days, 40 days, 150 days post operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraocular Lens</intervention_name>
    <description>Phacoemulsification with in the bag implantation of the IOL</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Aurovue, Model HP757SQ</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40 to 65 years

          -  Senile Cataract

          -  Posterior Subcapsular Cataract (PSCC)

        Exclusion Criteria:

          -  Obviously debilitated patients

          -  Cardiac and other serious illness

          -  Diabetic Patients

          -  Traumatic cataract

          -  Complicated cataract

          -  Congenital cataract

          -  Drug induced cataract

          -  Shallow anterior chamber

          -  Poor mydriasis

          -  Amblyopia

          -  Pseudo exfoliation (PXF)

          -  Dense posterior polar cataract (PPC)

          -  One eyed patients

          -  Glaucoma

          -  Uveitis

          -  Corneal Pathology

          -  Retinal Pathology

          -  Intra operative complications like PC rupture, Zonular dialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haripriya Aravind, MBBS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aravind Eye Hospital, Madurai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aravind Eye Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625020</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2007</study_first_submitted>
  <study_first_submitted_qc>March 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2007</study_first_posted>
  <last_update_submitted>February 10, 2009</last_update_submitted>
  <last_update_submitted_qc>February 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Haripriya Aravind</name_title>
    <organization>Aravind Eye Hospital</organization>
  </responsible_party>
  <keyword>Lenses, Intraocular</keyword>
  <keyword>Prospective Studies</keyword>
  <keyword>Visual acuity</keyword>
  <keyword>Clinical Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

